NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
sodium [(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)(methyl)amino]methanesulfonate
|
|
|
IUPAC Traditional name
|
sodium metamizole(1-)
|
potassium [(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)(methyl)amino]methanesulfonate
|
|
|
Brand Name
|
Alginodia
|
Algocalmin
|
Algopyrine
|
Bonpyrin
|
Conmel
|
Di-podil
|
Dimethone
|
Diprofarn
|
Farmolisina
|
Feverall
|
Fevonil
|
Gifaril
|
Keypyrone
|
Metapyrin
|
Methylmelubrin
|
Metilon
|
Narone
|
Neo-melubrine
|
Neomelurbrin
|
Nevralgina
|
Novaldin
|
Novalgetol
|
Noveltex
|
Optalgin
|
Paralgin
|
Pharmalgine
|
Pyralgin
|
Pyretin
|
Pyrojec
|
Sulpin
|
Sulpyrin
|
Sulpyrine
|
Sulpyrinum
|
Barone
|
Analgin
|
Novalgin
|
|
|
Synonyms
|
Dipyrone
|
Metamizol monohydrate
|
Metamizolum natricum [latin]
|
Methampyrone
|
Methylaminoantipyrine sodium methanesulfonate
|
Methylaminophenyldimethylpyrazolone methanesulfonate sodium
|
Analgine
|
Analginum
|
ARPF
|
Dipyrone
|
Aminopyrine sodium sulfonate
|
Dipyrone monohydrate
|
Metamizole
|
Metamizole sodique [inn-french]
|
Metamizole sodium
|
Metamizolnatrium
|
Metamizolo sodico [dcit]
|
Metamizolo [italian]
|
Metamizolum
|
Metamizolum natricum [inn-latin]
|
Metamizol sodico [spanish]
|
Metamizol
|
Meamizol sodico [inn-spanish]
|
安乃近
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
-1.2302347
|
H Acceptors
|
6
|
H Donor
|
0
|
LogD (pH = 5.5)
|
-2.2487726
|
LogD (pH = 7.4)
|
-2.2488215
|
Log P
|
-0.8157939
|
Molar Refractivity
|
78.9195 cm3
|
Polarizability
|
30.30252 Å3
|
Polar Surface Area
|
83.99 Å2
|
Rotatable Bonds
|
4
|
Lipinski's Rule of Five
|
true
|
Log P
|
1.07
|
LOG S
|
-1.76
|
Solubility (Water)
|
5.80e+00 g/l
|
DETAILS
DETAILS
DrugBank
Sigma Aldrich
DrugBank -
DB04817
|
Item |
Information |
Drug Groups
|
withdrawn |
Description
|
Dipyrone, formerly marketed as Dimethone tablets and injection, Protemp oral liquid, and other drug products, was associated with potentially fatal agranulocytosis. Approvals of the NDA's for dipyrone drug products were withdrawn on June 27, 1977 (see the Federal Register of June 17, 1977 (42 FR 30893)). Withdrawn from the Canadian market in 1963. |
Indication |
Used in the past as a powerful painkiller and fever reducer. |
Pharmacology |
Dipyrone is a non-steroidal anti-inflammatory drug (NSAID), commonly used in the past as a powerful painkiller and fever reducer. |
Affected Organisms |
• |
Humans and other mammals |
|
External Links |
|
|
Sigma Aldrich -
D8890
|
Biochem/physiol Actions A non-steroidal anti-inflammatory drug that, when coadministered with morphine, potentiates its antinociceptive action and delays the development of tolerance. Dipyrone is a relatively selective inhibitor of cyclooxygenase-3 (COX-3), with lower activity against COX-1 and no activity against COX-2. Blocks PGE2-induced hyperalgesia in several models. |
PATENTS
PATENTS
PubChem Patent
Google Patent